NRIX - Nurix Therapeutics, Inc.
17.08
0.590 3.454%
Share volume: 1,116,174
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$16.49
0.59
0.04%
View ratios
| Fiscal Date | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-11-2024 | 10-11-2024 | 01-28-2025 | 04-08-2025 | 07-09-2025 | 10-09-2025 | 01-28-2026 | 04-08-2026 | |
| Cash flow financing | 237.752 M | 45.770 M | 200.521 M | 1.473 M | 6.000 K | 1.155 M | 236.008 M | 19.975 M | |
| Other financing cash flows | 0.000 | 3.035 M | 1.449 M | 221.000 K | 6.000 K | 178.000 K | 1.246 M | 375.000 K | |
| Cash flow | -39.705 M | -17.746 M | 10.953 M | -34.081 M | 8.344 M | -5.755 M | 168.522 M | -175.765 M | |
| Net income | -44.546 M | -48.956 M | -58.549 M | -56.351 M | -43.464 M | -86.421 M | -78.221 M | -87.174 M | |
| Depreciation | 4.091 M | 2.394 M | 2.549 M | 2.350 M | 2.242 M | 2.028 M | 2.120 M | 2.196 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -131.070 M | -21.339 M | -140.817 M | 25.533 M | 71.499 M | 50.475 M | 346.000 K | -123.826 M | |
| Net Borrowings | -421.398 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.937 M | 2.347 M | 2.105 M | 3.485 M | 2.675 M | 2.711 M | 5.131 M | 1.045 M | |
| Cash Change | 443.139 M | -17.746 M | 10.953 M | -34.081 M | 8.344 M | -5.755 M | 168.522 M | -175.765 M |